Snowden Capital Advisors LLC Abb Vie Inc. Transaction History

Snowden Capital Advisors LLC

  • $3.29 Billion
  • Q3 2024

A detailed history of Snowden Capital Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 116,478 shares of ABBV stock, worth $19.5 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
116,478
Previous 127,617 8.73%
Holding current value
$19.5 Million
Previous $21.9 Million 5.09%
% of portfolio
0.7%
Previous 0.66%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$163.84 - $199.33 $1.83 Million - $2.22 Million
-11,139 Reduced 8.73%
116,478 $23 Million
Q2 2024

Aug 14, 2024
SELL
$154.79 - $180.76 $2.2 Million - $2.57 Million
-14,228 Reduced 10.03%
127,617 $21.9 Million
Q1 2024

May 15, 2024
BUY
$159.82 - $182.1 $2.62 Million - $2.99 Million
16,394 Added 13.07%
141,845 $25.8 Million
Q4 2023

Feb 14, 2024
SELL
$137.6 - $154.97 $129,206 - $145,516
-939 Reduced 0.74%
125,451 $19.4 Million
Q3 2023

Nov 14, 2023
SELL
$133.59 - $154.65 $392,621 - $454,516
-2,939 Reduced 2.27%
126,390 $18.8 Million
Q2 2023

Aug 14, 2023
BUY
$132.51 - $164.9 $708,000 - $881,060
5,343 Added 4.31%
129,329 $17.4 Million
Q1 2023

May 15, 2023
BUY
$144.61 - $166.54 $305,416 - $351,732
2,112 Added 1.73%
123,986 $19.8 Million
Q4 2022

Feb 13, 2023
BUY
$138.31 - $165.87 $547,707 - $656,845
3,960 Added 3.36%
121,874 $19.7 Million
Q3 2022

Nov 09, 2022
BUY
$134.21 - $153.93 $2.85 Million - $3.27 Million
21,265 Added 22.0%
117,914 $15.8 Million
Q2 2022

Aug 12, 2022
BUY
$137.62 - $174.96 $817,325 - $1.04 Million
5,939 Added 6.55%
96,649 $14.8 Million
Q1 2022

May 16, 2022
BUY
$131.98 - $163.75 $3.14 Million - $3.9 Million
23,792 Added 35.55%
90,710 $14.7 Million
Q4 2021

Feb 14, 2022
BUY
$107.43 - $135.93 $7.19 Million - $9.1 Million
66,918 New
66,918 $9.06 Million
Q3 2021

Feb 05, 2024
SELL
$106.4 - $120.78 $5.51 Million - $6.25 Million
-51,772 Reduced 40.96%
74,618 $8.05 Billion
Q2 2021

Jan 08, 2024
BUY
$105.21 - $117.21 $704,696 - $785,072
6,698 Added 10.82%
68,609 $7.73 Billion
Q1 2021

Jan 08, 2024
BUY
$102.3 - $112.62 $919,472 - $1.01 Million
8,988 Added 16.98%
61,911 $6.7 Billion
Q4 2020

Jan 08, 2024
BUY
$80.49 - $108.67 $131,118 - $177,023
1,629 Added 3.18%
52,923 $5.67 Billion
Q3 2020

Jan 08, 2024
SELL
$85.91 - $100.83 $91,236 - $107,081
-1,062 Reduced 2.03%
51,294 $4.49 Billion
Q2 2020

Jan 08, 2024
BUY
$73.37 - $98.18 $625,919 - $837,573
8,531 Added 19.47%
52,356 $5.14 Billion
Q1 2020

Jan 08, 2024
BUY
$64.5 - $97.79 $172,924 - $262,174
2,681 Added 6.52%
43,825 $3.34 Billion
Q4 2019

Jan 30, 2024
BUY
$72.13 - $90.25 $1.51 Million - $1.89 Million
20,986 Added 104.11%
41,144 $3.64 Billion
Q4 2019

Jan 08, 2024
BUY
$72.13 - $90.25 $1.51 Million - $1.89 Million
20,986 Added 104.11%
41,144 $3.64 Billion
Q3 2019

Jan 30, 2024
SELL
$62.98 - $75.72 $108,892 - $130,919
-1,729 Reduced 7.9%
20,158 $1.53 Billion
Q3 2019

Jan 08, 2024
SELL
$62.98 - $75.72 $1.01 Million - $1.21 Million
-16,005 Reduced 44.26%
20,158 $1.53 Billion
Q2 2019

Jan 30, 2024
SELL
$65.7 - $83.98 $6.87 Million - $8.78 Million
-104,503 Reduced 82.68%
21,887 $1.59 Billion
Q2 2019

Jan 08, 2024
BUY
$65.7 - $83.98 $993,843 - $1.27 Million
15,127 Added 71.91%
36,163 $1.6 Billion
Q1 2019

Jan 08, 2024
BUY
$77.14 - $90.79 $13,576 - $15,979
176 Added 0.84%
21,036 $1.7 Billion
Q4 2018

Jan 08, 2024
SELL
$77.85 - $96.01 $201,942 - $249,049
-2,594 Reduced 11.06%
20,860 $1.92 Billion
Q3 2018

Jan 08, 2024
BUY
$88.91 - $98.84 $180,220 - $200,348
2,027 Added 9.46%
23,454 $2.22 Billion
Q2 2018

Jan 08, 2024
BUY
$89.78 - $106.23 $74,696 - $88,383
832 Added 4.04%
21,427 $1.99 Billion
Q1 2018

Jan 08, 2024
BUY
$92.01 - $123.21 $217,143 - $290,775
2,360 Added 12.94%
20,595 $1.95 Billion
Q4 2017

Jan 08, 2024
BUY
$89.56 - $98.21 $281,845 - $309,066
3,147 Added 20.86%
18,235 $1.76 Billion
Q3 2017

Jan 08, 2024
BUY
$69.85 - $89.22 $179,095 - $228,760
2,564 Added 20.47%
15,088 $1.34 Billion
Q2 2017

Jan 08, 2024
BUY
N/A
897 Added 7.71%
12,524 $908 Million
Q1 2017

Jan 08, 2024
BUY
N/A
2,578 Added 28.49%
11,627 $758 Million
Q4 2016

Jan 08, 2024
BUY
N/A
2,074 Added 29.73%
9,049 $567 Million
Q3 2016

Jan 08, 2024
SELL
N/A
-7,312 Reduced 51.18%
6,975 $440 Million
Q2 2016

Jan 08, 2024
BUY
N/A
7,181 Added 101.06%
14,287 $884 Million
Q1 2016

Jan 08, 2024
SELL
N/A
-119,284
7,106 $406 Million

Others Institutions Holding ABBV

# of Institutions
3,846
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email